Leading the Charge by Dr. Rahul Ravilla: The Newer Immune-Related Side-Effects Impacts Continuity of Care in Individuals with Cancer on Immune Checkpoint InhibitorsJournal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.2, No. 3)
Publication Date: 2019-05-10
Immunotherapy agents for treatment of cancer have been explored for several decades, but effective drugs have only recently been identified and are increasingly being used in multiple cancer types.
Other Latest Articles
Last modified: 2020-02-26 23:47:54